Literature DB >> 20071829

Irrational fixed dose combinations in Nepal: need for intervention.

A Poudel1, S Palaian, P R Shankar, J Jayasekera, M I Izham.   

Abstract

A large proportion of drugs available are of little importance in terms of fulfilling primary healthcare needs. Combination drugs increase the risk of side effects, lead to an ineffective dosage and liability to abuse and may also needlessly increase the cost. Drug combinations make it more difficult to find the causative agent responsible for the adverse reactions. In many cases their stability is doubtful, reducing the efficacy of many preparations. The Fifteenth WHO model list of essential medicines (March 2007) contains only 25 approved fixed dose combinations, whereas in Nepal, there are innumerable examples of irrational drug combinations, which are easily available and can be bought even without a prescription. A system of screening the drug combinations that are already licensed and available in the market is implemented in many developed and developing countries. Rational combinations can be of immense help to the health care system. These combinations may improve the quality of life for many and increase compliance. But irrational fixed dose combination products can be equally harmful.

Mesh:

Substances:

Year:  2008        PMID: 20071829     DOI: 10.3126/kumj.v6i3.1723

Source DB:  PubMed          Journal:  Kathmandu Univ Med J (KUMJ)        ISSN: 1812-2027


  8 in total

Review 1.  Initiation of social pharmacy research in Nepal: our experiences.

Authors:  Subish Palaian; Arjun Poudel; Kadir Alam; Mohamed Izham Mohamed Ibrahim; Pranaya Mishra
Journal:  Int J Clin Pharm       Date:  2011-08

2.  Herbal Fixed Dose Combinations in Nepal: Growing Concerns in a Developing Country.

Authors:  Arjun Poudel; Kadir Alam; Subish Palaian; Mohamed Izham Mohamed Ibrahim
Journal:  J Clin Diagn Res       Date:  2016-10-01

3.  A need for the standardization of the pharmaceutical sector in Libya.

Authors:  Asma Abubakr Mustafa; Stefan Robert Kowalski
Journal:  Libyan J Med       Date:  2010-10-21       Impact factor: 1.657

4.  An evaluation of knowledge, attitude and practices about prescribing fixed dose combinations among resident doctors.

Authors:  Nimit Goswami; Anuradha Gandhi; Prakruti Patel; Ramkumar Dikshit
Journal:  Perspect Clin Res       Date:  2013-04

5.  A study of use of fixed dose combinations in Ahmedabad, India.

Authors:  Jayeshbhai Dineshchandra Balat; Anuradha M Gandhi; Prakruti P Patel; Ram K Dikshit
Journal:  Indian J Pharmacol       Date:  2014 Sep-Oct       Impact factor: 1.200

6.  Pattern of adverse drug reactions reported by the community pharmacists in Nepal.

Authors:  Subish Palaian; Mohamed I M Ibrahim; Pranaya Mishra
Journal:  Pharm Pract (Granada)       Date:  2010-03-15

7.  Assessment of utilization pattern of fixed dose drug combinations in primary, secondary and tertiary healthcare centers in Nepal: a cross-sectional study.

Authors:  Arjun Poudel; Mohamed Izham Mohamed Ibrahim; Pranaya Mishra; Subish Palaian
Journal:  BMC Pharmacol Toxicol       Date:  2017-11-02       Impact factor: 2.483

8.  Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal.

Authors:  Sunil Shrestha; Krisha Danekhu; Bhuvan Kc; Subish Palaian; Mohamed Izham Mohamed Ibrahim
Journal:  Ther Adv Drug Saf       Date:  2020-06-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.